NeoGenomics, Inc. Current Liabilities
NeoGenomics, Inc. (NEO) had Current Liabilities of $105.88 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-28
- 2026-06-30: Liabilities, Current $105.88M.
- 2026-03-31: Liabilities, Current $84.59M.
- 2025-12-31: Liabilities, Current $88.30M.
- 2025-09-30: Liabilities, Current $97.87M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $105.88M 10-Q · filed 2026-07-28 | |
| 2026-03-31 | $84.59M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $88.30M 10-Q · filed 2026-07-28 | |
| 2025-09-30 | $97.87M 10-Q · filed 2025-10-28 | |
| 2025-06-30 | $100.12M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $279.69M 10-Q · filed 2025-04-29 | |
| 2024-12-31 | $301.24M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $296.41M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $289.96M 10-Q · filed 2024-07-30 | |
| 2024-03-31 | $76.71M 10-Q · filed 2024-04-30 | |
| 2023-12-31 | $96.30M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $92.93M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $94.85M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $86.61M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $89.93M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $85.00M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $82.67M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $82.07M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $87.23M 10-K · filed 2023-02-24 | |
| 2021-09-30 | $92.74M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $99.13M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $67.75M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $73.18M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $64.61M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $61.70M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $67.65M 10-Q · filed 2020-04-29 | |
| 2019-12-31 | $63.90M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $68.91M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $59.16M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $72.70M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $60.92M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $47.05M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $47.97M 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $43.30M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $36.47M 10-K · filed 2019-02-26 | $35.06M 10-K · filed 2018-03-13 |
| 2017-09-30 | $40.11M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $35.20M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $39.88M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $38.11M 10-K · filed 2018-03-13 | |
| 2016-09-30 | $35.39M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $34.95M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $34.32M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $40.06M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $15.33M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $15.13M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $13.86M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $14.62M 10-K · filed 2016-04-18 | |
| 2014-09-30 | $13.95M 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $15.23M 10-Q · filed 2014-07-29 | |
| 2014-03-31 | $15.23M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $14.32M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $12.25M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $12.06M 10-Q · filed 2013-08-02 | |
| 2013-03-31 | $11.95M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $17.76M 10-K · filed 2014-02-24 | |
| 2012-09-30 | $16.67M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $15.10M 10-Q/A · filed 2012-08-15 | |
| 2012-03-31 | $14.75M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $11.44M 10-K · filed 2013-02-21 | |
| 2011-09-30 | $10.54M 10-Q · filed 2011-10-25 | |
| 2011-06-30 | $10.11M 10-Q/A · filed 2011-08-01 | |
| 2010-12-31 | $9.17M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |